Chemoinformaics analysis of 1-METHYL-9H-PYRIDO[3,4-B]INDOLE
| Molecular Weight | 182.226 | nRot | 0 |
| Heavy Atom Molecular Weight | 172.146 | nRig | 15 |
| Exact Molecular Weight | 182.084 | nRing | 3 |
| Solubility: LogS | -2.545 | nHRing | 2 |
| Solubility: LogP | 2.788 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 15 |
| nHA | 1 | APOL | 28.9079 |
| nHD | 1 | BPOL | 11.7421 |
| QED | 0.568 |
| Synth | 2.017 |
| Natural Product Likeliness | 0.307 |
| NR-PPAR-gamma | 0.041 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.005 |
| HIA | 0.005 |
| CACO-2 | -4.727 |
| MDCK | 0.0000215 |
| BBB | 0.937 |
| PPB | 0.861618 |
| VDSS | 1.43 |
| FU | 0.097569 |
| CYP1A2-inh | 0.989 |
| CYP1A2-sub | 0.944 |
| CYP2c19-inh | 0.6 |
| CYP2c19-sub | 0.632 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.839 |
| CYP2d6-inh | 0.797 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.584 |
| CYP3a4-sub | 0.39 |
| CL | 4.281 |
| T12 | 0.416 |
| hERG | 0.03 |
| Ames | 0.813 |
| ROA | 0.953 |
| SkinSen | 0.662 |
| Carcinogencity | 0.494 |
| EI | 0.979 |
| Respiratory | 0.988 |
| NR-Aromatase | 0.746 |
| Antiviral | No |
| Prediction | 0.619408 |